Insider Trading - King Rachel K.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for King Rachel K.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-19
Purchase
2021-05-21
5:06 pm
NOVAVAX INC King Rachel K.
Director
700 $139.64 $97,748 5,000
(Indirect
Direct)
View
2020-12-28
Sale
2020-12-30
4:00 pm
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
84,176 $3.91 $329,128 531,206
(Indirect
Direct)
View
2019-03-27
Purchase
2019-03-28
4:21 pm
NOVAVAX INC King Rachel K.
Director
86,000 $0.5298 $45,563 64,000
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-06-25(A)
Exercise
2021-08-20
5:29 pm
N/A
N/A
NOVAVAX INC King Rachel K.
Director
3,450 $0 9,700
(Direct)
View
2021-06-25
Exercise
2021-06-29
5:14 pm
N/A
N/A
NOVAVAX INC King Rachel K.
Director
6,900 $0 11,900
(Direct)
View
2021-06-17
Option Award
2021-06-22
5:18 pm
2022-06-17
2031-06-17
NOVAVAX INC King Rachel K.
Director
2,000 $0 2,000
(Direct)
View
2021-01-20
Option Award
2021-01-22
4:00 pm
N/A
2031-01-19
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
288,750 $0 819,956
(Direct)
View
2020-12-28
Exercise
2020-12-30
4:00 pm
N/A
2021-01-04
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
130,821 $0 531,206
(Direct)
View
2020-12-28
Exercise
2020-12-30
4:00 pm
N/A
N/A
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
130,821 $1.12 531,206
(Direct)
View
2020-06-25
Option Award
2020-06-26
9:18 pm
2021-06-25
2030-06-25
NOVAVAX INC King Rachel K.
Director
10,350 $0 10,350
(Direct)
View
2020-01-22
Option Award
2020-01-24
4:14 pm
N/A
2030-01-21
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
349,000 $0 349,000
(Direct)
View
2019-12-12
Option Award
2019-12-16
5:00 pm
2020-12-12
2029-12-12
NOVAVAX INC King Rachel K.
Director
18,000 $0 18,000
(Direct)
View
2019-08-06
Exercise
2019-08-07
4:29 pm
N/A
2021-01-04
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
166,759 $0 615,382
(Direct)
View
2019-08-06
Exercise
2019-08-07
4:29 pm
N/A
N/A
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
166,759 $1.12 615,382
(Direct)
View
2019-01-17
Option Award
2019-01-22
6:22 pm
N/A
2029-01-16
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
265,000 $0 265,000
(Direct)
View
2018-10-31
Option Award
2018-11-02
4:41 pm
2019-10-31
2028-10-31
NOVAVAX INC King Rachel K.
Director
160,000 $0 160,000
(Direct)
View
2017-12-31
Ownership
2018-02-14
08:52 am
N/A
N/A
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
0 $0 317,802
(Direct)
View
2017-12-31
Ownership
2018-02-14
08:52 am
N/A
N/A
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
69,903 $0 317,802
(Indirect)
View
2018-01-10
Option Award
2018-01-12
4:04 pm
N/A
2028-01-09
GLYCOMIMETICS INC GLYC King Rachel K.
CEO
175,000 $0 175,000
(Direct)
View
(A) Indicate amendment filing.